Trials / Sponsors / Kallyope Inc.
Kallyope Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of K-645 in the Treatment of Multiple Migraine Attacks Acute Migraine | Phase 2 | 2025-08-12 |
| Completed | A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migr Acute Migraine | Phase 2 | 2025-03-05 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Ove Obesity, Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2023-12-07 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With Obesity | Phase 2 | 2023-09-15 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Obesity, Type 2 Diabetes Mellitus in Obese | Phase 1 | 2023-03-13 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overw Obesity | Phase 1 | 2022-09-21 |